Federal Register :: Office of Women's Health Strategic Priorities; Establishment of a Public Docket; Request for Comments

Federal Register :: Office of Women's Health Strategic Priorities; Establishment of a Public Docket; Request for Comments

FDA Office of Women’s Health is Seeking Your Feedback on Strategic Priorities

To maximize the FDA Office of Women’s Health’s ability to promote, protect, and advance the health of women, they are seeking input on research priorities driven by data gaps and areas of unmet need; topics for education among consumers, health professionals, and other stakeholders; and outreach to women, especially underserved and diverse populations. They are also interested in proposed methods for acting on these priorities, such as collaborations and partnerships.          

Therefore, FDA is issuing a Federal Register notice to open Docket No. FDA-2020-N-1391 for the public to submit comments. FDA will take the suggestions and information submitted to the docket into consideration when developing OWH scientific, educational, and outreach priorities.

Submit either electronic or written comments by September 8, 2020.     

Read the Federal Register Notice.